WINNIPEG, MANITOBA--(Marketwire - March 04, 2008) - Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce that it has retained BioVectra Inc., a biopharmaceutical company in Atlantic Canada, to manufacture clinical grade DispersinB™ to be used in the Company's wound care product being developed for treating chronic wounds.
